Zhang Tianyi, Ye Xiaofei, Guo Xiaojing, Wu Guizhi, Hou Yongfang, Xu Jinfang, Shi Wentao, Zhu Tiantian, Zhang Yuan, Zhang Xinji, Song Jiaqi, He Jia
Department of Health Statistics, Second Military Medical University, Shanghai, 200433, China.
National Center for ADR Monitoring, Beijing, 100045, China.
Drug Saf. 2017 Apr;40(4):343-350. doi: 10.1007/s40264-016-0503-0.
The method of time-to-onset (TTO) has been proposed to overcome the drawbacks of traditional disproportionality analyses (DPAs), and it has been used for detecting safety signals of vaccines and some non-vaccine products in spontaneous reporting systems (SRSs). However, there is no consensus on its superiority over DPAs. Further, it is still not clear whether this novel approach can be generalized to the entire national SRS database.
The purpose of this study was to generalize the TTO method to the Chinese SRS and to identify suitable parameters for its optimal performance.
Reports submitted to the national SRS of China in 2014 were used as the data source for analysis. We evaluated the performance of TTO by using product labels as proxies for the gold standard. A series of values of significance level and time windows were explored to identify the most suitable parameters for TTO based on Youden's index, a statistic that summarizes the performance of a diagnostic test. Additionally, we compared TTO with traditional DPAs and explored the characteristics of signals detected by these methods.
Compared with DPAs, TTO had a lower sensitivity, but higher specificity and positive predictive value. At a significance level of 0.2 and no restrictions on time windows, TTO had the highest Youden's index. The kappa coefficients between TTO and DPAs were rather low, indicating poor agreement between the two methods. More than 30% of the true signals detected by TTO were not identified by DPAs. Furthermore, TTO needed more number of reports to be able to detect signals.
TTO can detect signals missed by traditional DPAs and could be an important complementary tool to the currently used DPAs in the SRS of China. We recommend a significance level of 0.2 and no restrictions on time windows for TTO.
已提出发病时间(TTO)方法以克服传统不成比例分析(DPA)的缺点,并且该方法已用于在自发报告系统(SRS)中检测疫苗和一些非疫苗产品的安全信号。然而,关于其相对于DPA的优越性尚无共识。此外,尚不清楚这种新方法是否可以推广到整个国家SRS数据库。
本研究的目的是将TTO方法推广到中国SRS,并确定其最佳性能的合适参数。
将2014年提交至中国国家SRS的报告用作分析的数据源。我们以产品标签作为金标准的替代物来评估TTO的性能。探索了一系列显著性水平和时间窗的值,以基于约登指数确定TTO最合适的参数,约登指数是一种总结诊断测试性能的统计量。此外,我们将TTO与传统DPA进行了比较,并探讨了这些方法检测到的信号特征。
与DPA相比,TTO的敏感性较低,但特异性和阳性预测值较高。在显著性水平为0.2且对时间窗无限制的情况下,TTO具有最高的约登指数。TTO与DPA之间的kappa系数相当低,表明这两种方法之间的一致性较差。TTO检测到的超过30%的真实信号未被DPA识别。此外,TTO需要更多数量的报告才能检测到信号。
TTO可以检测到传统DPA遗漏的信号,并且可能是中国SRS中当前使用的DPA的重要补充工具。我们建议TTO的显著性水平为0.2且对时间窗无限制。